Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07215429 · ClinicalTrials.gov registry record

SpO2 Validation Study-Philips Optimus

A clinical trial, sponsored by Philips Clinical & Medical Affairs Global.

Terminated
Registry status
24
Enrollment target

NCT07215429 is a clinical trial that was terminated before completion, run by Philips Clinical & Medical Affairs Global. The registered enrollment target is 24 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07215429 was terminated before completion, sponsored by Philips Clinical & Medical Affairs Global.

TERMINATED
Registry status
24 participants
Enrollment target

Study Summary

Validation study to validate the SpO2 accuracy performance of the Sponsor's SpO2 sensors over the range of 70-100% SaO2 during non-motion conditions assessed by CO-Oximetry

Interventions

  • DEVICE No intervention

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2025-09-09
Est. Completion 2025-09-19

What the Registry Record Tells You About NCT07215429

The ClinicalTrials.gov registry entry for NCT07215429 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Philips Clinical & Medical Affairs Global, which has 45 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which No intervention is the first listed.

NCT07215429 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07215429 about?

NCT07215429 is a clinical study titled "SpO2 Validation Study-Philips Optimus". Validation study to validate the SpO2 accuracy performance of the Sponsor's SpO2 sensors over the range of 70-100% SaO2 during non-motion conditions assessed by CO-Oximetry

What is the current status of trial NCT07215429?

This trial is currently terminated. The enrollment target is 24 participants. The study started on 2025-09-09. Estimated completion is 2025-09-19.

What interventions are being tested in trial NCT07215429?

The interventions under investigation include: No intervention (DEVICE).

Who is sponsoring clinical trial NCT07215429?

This trial is sponsored by Philips Clinical & Medical Affairs Global, which has 45 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.